Mesoblast (MESO) Amortization of Deferred Charges (2014 - 2023)
Powered by 
Analysis
Mesoblast (MESO) Amortization of Deferred Charges (2014 - 2023) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Mesoblast | 2.24 Bn | 2.14 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2023 | 4.45 Mn |
| Mar 31, 2023 | 4.99 Mn |
| Dec 31, 2022 | 6.13 Mn |
| Sep 30, 2022 | 4.55 Mn |
| Jun 30, 2022 | 4.35 Mn |
| Mar 31, 2022 | 3.90 Mn |
| Dec 31, 2021 | 4.90 Mn |
| Sep 30, 2021 | 4.14 Mn |
| Sep 30, 2020 | 2.53 Mn |
| Sep 30, 2019 | 2.17 Mn |
| Sep 30, 2018 | 1.76 Mn |
| Dec 31, 2016 | 614,000.00 |
| Sep 30, 2016 | 1.04 Mn |
| Jun 30, 2016 | 1.77 Mn |
| Dec 31, 2015 | 2.03 Mn |
| Sep 30, 2015 | 2.42 Mn |
| Jun 30, 2015 | 1.34 Mn |
| Sep 30, 2014 | 1.94 Mn |